LecturaInvestigaciónRadarMarco de inversión
Iniciar sesión / Registrarse
← Volver a la lectura
NoticiasTema · 英伟达生物计算拓展Material1 min de lecturaEditorial de DisconfirmAI

NVIDIA and IPD: Showcasing How AI Moves from Computer Models to Lab Protein Design

NVIDIA Research and the University of Washington's Institute for Protein Design (IPD) released a video detailing the RFD4-Proteina project. Led by Nobel Laureate David Baker, the collaboration demonstrates how AI-generated protein designs are transitioned from computer models into laboratory testing, including work on enzymes that break down pesticides.

2026-10-21 19:30 GMT+8

NVIDIA has published a video on its official channel regarding the "RFD4-Proteina" project, highlighting its collaboration with the University of Washington's Institute for Protein Design (IPD). The IPD is founded and led by Nobel Laureate in Chemistry David Baker, a leading authority in the field of protein design.

According to the video description, the joint team demonstrates how to move AI-generated protein design proposals from computer models into actual laboratory testing. This process aims to combine protein design research with computational efficiency to explore new approaches to challenges in chemistry, medicine, and the environment. The video specifically mentions work on designing enzymes capable of breaking down pesticides, illustrating the potential of AI in solving specific environmental problems and developing novel biocatalysts.

For readers interested in the practical utility of AI in scientific research, this resource offers a window into the collaboration model between top-tier research institutions and computing giants. Although a full technical paper or transcript is not provided, the officially released demonstration confirms the existence of this partnership and its primary direction: using generative AI to accelerate the closed loop from sequence prediction to wet-lab validation.

Fuentes

Iniciar sesión / Registrarse
LecturaInvestigaciónRadarMarco de inversión
youtube.com↗
Tema

英伟达生物计算拓展

英伟达正加速渗透生命科学领域,试图通过开源模型与硬件集群构建AI制药基础设施。2026年10月,英伟达联合华盛顿大学医学蛋白质设计研究所(IPD)发布RFD4-Proteina开源模型,宣称其计算设计成功率优于基线,并已与亚马逊、OpenA…

4 pasos3 piezasActualizado 2026-10-22 16:59

Cómo llegó hasta aquí

  1. 2026-03-16瑞士药企罗氏宣布与英伟达扩大合作,新增2,176个Blackwell GPU,旨在打造业界最大的混合云AI工厂以加速药物开发。fiercebiotech.com ↗
  2. 2026-10-21英伟达在GTC柏林发布RFD4-Proteina开源蛋白质设计模型,并宣布与西门子医疗合作开发下一代自适应放疗系统。nvidianews.nvidia.com ↗
  3. 2026-10-22英伟达官方频道发布视频,展示Lila Sciences如何利用NVIDIA Nemotron和Agent Toolkit构建自主实验室工作流。youtube.com ↗

Lo que aún está pendiente

  • RFD4-Proteina在真实世界药物发现中的临床转化率是否显著高于传统方法?
  • 英伟达与金斯瑞等合作伙伴的生态模式能否有效解决AI设计与湿实验验证之间的脱节问题?
  • 随着AI深入医疗核心环节,监管机构对算法辅助诊断和治疗规划的审批标准将如何演变?

También en este hilo

  • NVIDIA video: Lila Sciences' AI agents and automated labs for drug discovery2026-10-22
  • NVIDIA Releases RFD4-Proteina Open Model for Protein Design, Claims Higher Success Rates Than Baselines2026-10-21
Leer el tema completo →
Continuar investigando →